AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Myosin Therapeutics Launches Phase 1/2 Trial of MT-125 in Newly Diagnosed Glioblastoma
PR Newswire says Myosin Therapeutics has initiated a Phase 1/2 STAR-GBM trial for MT-125 in newly diagnosed glioblastoma. The study adds another experimental approach to one of oncology’s most difficult diseases.
Peppermint Oil Trial Suggests an Unexpected, Low-Cost Path to Blood Pressure Control
A new clinical trial reported that peppermint oil may lower blood pressure, adding to the long list of natural products being explored for measurable cardiovascular effects. While the finding is preliminary, it could attract attention because it points to a simple, inexpensive intervention rather than a high-tech device or drug.
Harvard study puts AI triage ahead of doctors — and raises the bar for deployment
A Harvard-led trial suggests AI can outperform clinicians in emergency triage-style diagnostic decisions on difficult cases. The result is striking, but the bigger question is whether better test performance translates into safer care in real hospitals.
BrioHealth’s FDA Approval for BrioVAD Trial Marks a Key Step for Next-Generation Mechanical Circulatory Support
BrioHealth has won FDA approval to launch a trial of its BrioVAD system, advancing a potentially important device in the mechanical circulatory support space. The approval does not prove clinical success, but it does clear a key regulatory gate for a category where evidence generation is expensive and slow.
Nature Trial Suggests AI Can Sharply Improve Lung Nodule Diagnosis
A Nature-published clinical trial reports that an artificial intelligence model improved diagnostic accuracy for lung nodules, one of the most common and consequential findings in chest imaging. If the results hold up across broader settings, the tool could reduce uncertainty, speed referrals, and help clinicians better distinguish benign from malignant lesions.
Mammography AI Moves Closer to Standard of Care, But FDA Has Yet to Catch Up
A new review of the MASAI trial argues that AI-augmented mammography may already be functionally standard in some screening settings, even if U.S. regulators have not fully formalized that view. The disconnect highlights a growing problem in healthcare: evidence can move faster than policy.
TRiCares Wins FDA IDE for Pivotal Trial of Tricuspid Regurgitation Device
TRiCares has received FDA approval to begin an investigational device exemption pivotal trial for its tricuspid regurgitation treatment. The move brings another structural-heart therapy closer to the evidence base needed for commercialization and reimbursement.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.